Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

50.01
Delayed Data
As of Jun 24
 -1.36 / -2.65%
Today’s Change
49.51
Today|||52-Week Range
72.31
-23.81%
Year-to-Date
Allergan (AGN) Gets FDA Nod for Avycaz Label Expansion
Jun 24 / Zacks.com - Paid Partner Content
What Exactly Did Allergan and Teva Sell to Impax?
Jun 21 / TheStreet.com - Paid Partner Content
AstraZeneca, Teva Resolve Their Patent Row Over Diabetes Product
Jun 23 / TheStreet.com - Paid Partner Content
Here's Why Alphabet, Allergan and L Brands Will Take Off in Second Half
Jun 21 / TheStreet.com - Paid Partner Content
Impax (IPXL) Stock Declines on Deal to Buy Generic Products
Jun 22 / Zacks.com - Paid Partner Content
Why Is Impax Labs Tumbling 11.7% Today
Jun 21 / MotleyFool.com - Paid Partner Content
'Mad Money' Lightning Round: Be Patient on Alcoa
Jun 22 / TheStreet.com - Paid Partner Content
3 High-Growth Stocks You Don't Need to Babysit
Jun 17 / MotleyFool.com - Paid Partner Content
Is Opko Health a Buy Now That Rayaldee Is Approved?
Jun 21 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close51.37
Today’s open50.10
Day’s range49.98 - 51.30
Volume5,841,346
Average volume (3 months)5,957,604
Market cap$51.1B
Dividend yield2.72%
Data as of 4:03pm ET, 06/24/2016

Growth & Valuation

Earnings growth (last year)-48.62%
Earnings growth (this year)-3.18%
Earnings growth (next 5 years)+6.45%
Revenue growth (last year)-3.25%
P/E ratio25.9
Price/Sales2.89
Price/Book1.71

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc-0.79-4.02%
BGNEBeiGene Ltd-2.50-8.13%
OASMOasmia Pharmaceutica...-0.31-8.61%
VBLTVascular Biogenics L...-0.13-3.09%
Data as of 4:00pm ET, 06/24/2016

Financials

Next reporting dateJuly 28, 2016
EPS forecast (this quarter)$1.18
Annual revenue (last year)$19.6B
Annual profit (last year)$1.6B
Net profit margin8.09%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Tel Aviv

Forecasts

Partner Offers

Search for Jobs